Prevention of prostate cancer

Hematology/Oncology Clinics of North America

Volumn 15, Issue 3, 2001, Pages 445-457

  DePrimo, Samuel E ^a,b   Shinghal, Rajesh ^a   Vidanes, Genevieve ^a   Brooks, James D ^a  

^a JDB) ^*  (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; GENISTEIN; LYCOPENE; SELENIUM; SULFORAPHANE; VITAMIN D;

ANDROGEN METABOLISM; ANTIOXIDANT ACTIVITY; CANCER GROWTH; CANCER PREVENTION; DIETARY INTAKE; FAT INTAKE; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; VITAMIN INTAKE;

EID: 0034889736     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70225-2     Document Type: Article

References (79)

1. Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: Results of a randomized, double-blind, placebo-controlled clinical trial. PLESS Study Group. Proscar Long-term Efficacy and Safety Study
2. Vitamin D and prostate cancer
3. Prostate cancer and prediagnostic levels of serum vitamin D metabolites
4. Latent carcinoma of prostate of autopsy in seven areas
5. Prediagnostic serum selenium levels and the risk of prostate cancer development
6. Potent induction of carcinogen defence enzymes with sulforaphane, a putative prostate cancer chemopreventive agent
7. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia
8. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study
9. Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States
10. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: A randomized controlled trial
11. Cis-trans lycopene isomers, carotenoids, and retinol in the human prostate
12. Fruit and vegetable intakes and prostate cancer risk
13. Prostate Cancer Prevention Trial (PCPT) update
14. Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma
15. Vitamin D and prostate cancer: A prediagnostic study with stored sera
16. The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels
17. Epidemiologic aspects of latent and clinically manifest carcinoma of the prostate
18. Lycopene as the most efficient biological carotenoid singlet oxygen quencher
19. Smoking plasma vitamins C, E, retinol, and carotene, and fatal prostate cancer: Seventeen-year follow-up of the prospective Basel study
20. Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids
21. Broccoli sprouts: An exceptionally rich source of inducers of enzymes that protect against chemical carcinogens
22. Cancer of the prostate: A nutritional disease?
23. Vitamin D and prostate cancer
24. Diet, androgens, oxidative stress and prostate cancer susceptibility
25. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer
26. Lower prostate cancer risk in men with elevated plasma lycopene levels: Results of a prospective analysis
27. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: Complexities with thioredoxin reductase
28. A prospective study of dietary fat and risk of prostate cancer
29. Intake of carotenoids and retinol in relation to risk of prostate cancer
30. Tomatoes, tomato-based products, lycopene, and cancer: Review of the epidemiologic literature
31. Exisulind (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograft model by increasing apoptosis
32. Effects of finasteride (MK-906), a 5 alphareductase inhibitor, on circulating androgens in male volunteers
33. The effect of finasteride in men with benign prostatic hyperplasia
34. Cancer statistics 2000
35. Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol)
36. Prostate cancer chemoprevention by green tea
37. Studies of Japanese migrants: I. Mortality from cancer and other diseases among Japanese in the United States
38. Geographic patterns of prostate cancer mortality: Evidence for a protective effect of ultraviolet radiation
39. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: Incidence and mortality in a controlled trial
40. Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases
41. Chemoprevention of cancer: Selenium
42. The heterologous growth of cancer of the human prostate
43. Prostate visualization studies in males homozygous and heterozygous for 5 alpha-reductase deficiency
44. Lessons from basic research in selenium and cancer prevention
45. Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study
46. Invited commentary: Tomatoes, lycopene, and prostate cancer: How strong is the evidence?
47. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis
48. Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines
49. A randomized, placebo-controlled trial of low-dose alpha-difluoromethylornithine in individuals at risk for colorectal cancer
50. Models of DNA structure achieve almost perfect discrimination between normal prostate, benign prostatic hyperplasia (BPH), and adenocarcinoma and have a high potential for predicting BPH and prostate cancer
51. Vitamin D and prostate cancer: Biologic interactions and clinical potentials
52. High dietary omega-6 polyunsaturated fatty acids drastically increase the formation of etheno-DNA base adducts in white blood cells of female subjects
53. Phase II trial of oral 1,25 dihydroxyvitamin D (calcitriol) in hormone refractory prostate cancer
54. Fatty acids and prostate cancer: Current status and future challenges
55. Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate
56. Lycopene in association with alpha-tocopherol inhibits at physiological concentrations proliferation of prostate carcinoma cells
57. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin
58. Hormone resistance in prostate cancer
59. Insulin-like growth factors and prostate cancer
60. Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl) retinamide
61. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells
62. Effect of antioxidants on androgen-induced AP-1 and NF-kappaB DNA-binding activity in prostate carcinoma cells
63. Serum testosterone levels in healthy young black and white men
64. 5-Alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males
65. Androgen metabolism and prostate cancer: Establishing a model of genetic susceptibility
66. Is vitamin D deficiency a risk factor for prostate cancer? (hypothesis)
67. Possible protective effect of selenium against human cancer
68. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County
69. Lycopene: Antioxidant and biological effects and its bioavailability in the human
70. Sunlight: Can it prevent as well as cause cancer?
71. Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases
72. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers
73. Chemoprevention of prostate cancer: The Prostate Cancer Prevention Trial
74. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance
75. Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet
76. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer
77. A major inducer of anticarcinogenic protective enzymes from broccoli: Isolation and elucidation of structure
78. 1-Alpha,25-dihydroxy D3 action in LNCaP human prostate cancer cells are androgen-dependent
79. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice